Financials in USD. Standardized financial statements.
A compact view of how Haoxi Health Technology Limited turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue? | $32.80M | $48.52M | $28.23M | $16.16M | $12.85M |
| Revenue Growth? | -32.4% | +71.9% | +74.7% | +25.8% | 0.0% |
| Cost of Revenue? | $31.88M | $45.77M | $26.17M | $15.51M | $12.24M |
| Gross Profit? | $927,750 | $2.75M | $2.06M | $648,721 | $605,577 |
| Gross Margin? | +2.8% | +5.7% | +7.3% | +4.0% | +4.7% |
| Operating Expenses? | $2.93M | $1.03M | $866,255 | $379,953 | $275,023 |
| Operating Income? | -$2.00M | $1.72M | $1.20M | $268,770 | $330,550 |
| EBITDA? | $4.57M | $1.79M | $1.22M | $271,770 | $330,965 |
| Income Before Tax | $4.15M | $1.74M | $1.19M | $259,595 | $325,284 |
| Income Tax Expense | $270,744 | $443,582 | $220,653 | $15,008 | $21,219 |
| Net Income? | $3.88M | $1.29M | $969,752 | $244,587 | $304,065 |
| EPS? | $1.66 | $1.06 | $0.09 | $0.02 | $0.03 |
| Diluted EPS? | $1.32 | $1.06 | $0.09 | $0.02 | $0.03 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality